These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8116311)

  • 1. [Clinical experiences with the Medusa Cu 240 Ag intrauterine device].
    Girardi F
    Wien Klin Wochenschr; 1993; 105(24):728-31. PubMed ID: 8116311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The copper-7 intrauterine contraceptive device: 5-year evaluation.
    Sellors JW
    Can Med Assoc J; 1981 Oct; 125(7):717-20. PubMed ID: 7326653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-year study of the copper-7 minigravigard intrauterine contraceptive device in nulliparous women.
    Srisupandit S
    J Med Assoc Thai; 1988 Jun; 71(6):294-7. PubMed ID: 3171448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease.
    Suri V; Aggarwal N; Kaur R; Chaudhary N; Ray P; Grover A
    Contraception; 2008 Oct; 78(4):315-8. PubMed ID: 18847580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of side-effects of Cu-T as intra-uterine contraceptive device in post medical termination of pregnancy and interval cases.
    Das CR; Pradhan G
    J Indian Med Assoc; 1995 Oct; 93(10):375-6. PubMed ID: 9053409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of copper T as contraceptive after caesarean section.
    Parikh V; Gandhi AS
    J Indian Med Assoc; 1989 May; 87(5):113-5. PubMed ID: 2600433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrauterine contraception with copper-T 200 device- a retrospective analysis of 334 cases (author's transl)].
    Salzer H; Schneider WH; Eppel W
    Wien Klin Wochenschr; 1981 May; 93(11):354-8. PubMed ID: 7269615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
    Roy S; Azen C
    Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Presentation of a new IUD: the "Ombrelle 250"].
    Audebert AJ; Emperaire JC; Larue-charlus S
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):967-71. PubMed ID: 12267500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD].
    Elia D; Belaisch J
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of the follow-up of the position of intra-uterine device by ultra-sonography (author's transl)].
    Schmidt EH; Wagner H; Quakernack K; Beller FK
    Geburtshilfe Frauenheilkd; 1979 Feb; 39(2):138-43. PubMed ID: 761755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the performance of a copper intrauterine device: MLCu 375].
    Audebert A; Emperaire JC; Larue-charlus S
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1):13-6. PubMed ID: 12266608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Copper containing intrauterine devices. Clinical and social aspects].
    Beck A
    Fortschr Med; 1982 Sep; 100(33):1515-9. PubMed ID: 7129314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrauterine devices in general practice: a prospective study of 300 insertions].
    Marret H; Golfier F; Vollerin F; Legoaziou MF; Raudrant D
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):465-70. PubMed ID: 12379830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nova-T 200 intrauterine contraceptive device: a 12 year study.
    Baeyertz JD; Hartfield VJ
    N Z Med J; 1997 May; 110(1043):169-71. PubMed ID: 9196502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of a type of biomedicated IUD (model Copper 7 200) in a family planning clinic].
    Rocha AH; Peixoto RM; Rezende CA; Aleixo Neto A
    J Bras Ginecol; 1982; 92(1):11-3. PubMed ID: 12338187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of two techniques used in immediate postplacental insertion of TCu 380A intrauterine device: 12 month follow-up of 910 cases].
    Xu J; Zhuang L; Yu G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):354-7. PubMed ID: 9596916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.